Status | Study |
Recruiting |
Study Name: Phase 2 Durvalumab (Medi4736) for Bacillus Calmette-Guérin (BCG) Refactory Urothelial Carcinoma in Situ of the Bladder Condition: Carcinoma in Situ of Bladder Bladder Cancer Date: 2016-09-12 Interventions: Drug: Durvalumab Durvalumab wi |
Not yet recruiting |
Study Name: Comparative Effectiveness of Sentinel Lymph Node Biopsy for Ductal Carcinoma In Situ Condition: Ductal Carcinoma In Situ Date: 2016-08-30 Interventions: Procedure: Sentinel lymph node biopsy (SLNB) Intervention is defined as that the DCIS patient has underg |
Recruiting |
Study Name: Conjugated Estrogens/Bazedoxifene in Treating Patients With Ductal Carcinoma in Situ Undergoing Surgery Condition: Ductal Breast Carcinoma In Situ Postmenopausal Date: 2016-02-24 Interventions: Drug: Conjugated Estrogens/Bazedoxifene |
Recruiting |
Study Name: MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ Condition: Ductal Breast Carcinoma In Situ Date: 2015-01-16 Interventions: Procedure: Magnetic Resonance Imaging |
Active, not recruiting |
Study Name: Effects of Diet and Exercise on Ductal Carcinoma in Situ Condition: Ductal Carcinoma In Situ Breast Cancer Date: 2014-08-19 Interventions: Behavioral: Active Comparator: Progressive Resistance Training (PRT) and a h |
Recruiting |
Study Name: Pilot Study of Oxytocin and microRNA Identification in NAF, Serum, and Tissue in Women With Breast Cancer Condition: Breast Cancer Ductal Carcinoma in Situ Date: 2014-04-28 Interventions: Drug: Intranasal Oxytocin Intranasal spray, one spray or 4 IU of oxytocin will be administered into each |
Recruiting |
Study Name: Lavage of the Uterine Cavity for the Diagnosis of Serous Tubal Intraepithelial Carcinoma Condition: Ovarian Epithelial Cancer Carcinoma in Situ Date: 2014-01-16 Interventions: Procedure: Lavage of the Cavum uteri and proximal Fallopian tubes, performed in the luteal phase of the female cycle |
Active, not recruiting |
Study Name: Follow-up of Abnormal and Inadequate Smear-test Results Condition: Carcinoma in Situ of Uterine Cervix Date: 2013-11-29 Interventions: Other: Test result sent by letter Other: T |
Completed |
Study Name: Study With TMX-101 in Patients With Carcinoma In Situ (CIS) Bladder Cancer Condition: Carcinoma in Situ Non Muscle Invasive Bladder Cancer Date: 2012-11-12 Interventions: Drug: TMX-101 Other Name: Imiquimod |
Completed |
Study Name: Management of Ductal Carcinoma in Situ or Pure Micro-invasive Extended Breast Condition: Intraductal Carcinoma and Lobular Carcinoma in Situ Date: 2012-11-05 Interventions: Procedure: sentinel node biopsy and mastectomy sentinel node biopsy and mastectomy |